 | | PRD_000760 | | Name: | THIOPEPTIDE THIOSTREPTON OXIDIZED AT CA-CB BOND OF RESIDUE 9 | | Formula: | C69 H79 N18 O17 S5 | | Description: | THIOSTREPTON IS A HETEROCYCLIC THIOPEPTIDE,
CONSISTING OF FOUR THIAZOLES ONE THIOZOLINE
ONE PIPERIDEINE RINGS.
A MODIFIED QUINOLINE LINKED TO MAIN-CHAIN
RESIDUE 1 AND SIDE-CHAIN OF RESIDUE 12.
IN THIS ENTRY RESIDUE 9 WAS CHEMICALLY MODIFIED: THE
CA-CB BOND WAS OXIDIZED FROM SINGLE TO DOUBLE.
RESIDUE 17 (HET DHA) WAS DELETED. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000762 | | Name: | METHANOBACTIN MB-OB3B | | Formula: | C45 H56 Cu N10 O16 S5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000764 | | Name: | CYCLOSPORIN D, 5,7 mutation | | Formula: | C64 H117 N11 O12 S | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A,
OBTAINED IN DIFFERENT NUTRIENT BROTH AND
DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL).
THE CYCLOSPORIN D MOLECULE WAS MODIFIED AT
POSITIONS 5 AND 7 TO BE
(6,7-DIHYDRO)4-[(E)-BUTENYL]-4,N-DIMETHYL-THREONINE AND
(2-S-METHYL)-SARCOSINE, RESPECTIVELY. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000765 | | Name: | CYCLOSPORIN A, 5 mutation | | Formula: | C63 H113 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN WAS MODIFIED AT POSITION 5 TO BE
4-[(E)-2-BUTENYL]-4,4,N-TRIMETHYL-L-THREONINE | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000766 | | Name: | CYCLOSPORIN A, 6 mutation | | Formula: | C63 H113 N11 O13 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A MOLECULE WAS MODIFIED AT
POSITION 6 TO BE 2-AMINO-5-HYDROXYPENTANOIC ACID | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000767 | | Name: | CYCLOSPORIN A, 7 mutation | | Formula: | C63 H113 N11 O13 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A WAS MODIFIED AT POSITION 7
TO BE N-METHYL-D-SERINE | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000768 | | Name: | CYCLOSPORIN A, 8 mutation | | Formula: | C62 H111 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE.
CYCLIZATION IS ACHIEVED BY LINKING THE N- AND
THE C- TERMINI.
THE CYCLOSPORIN A MOLECULE WAS MODIFIED AT
POSITION 8 TO BE N-METHYL-ISOLEUCINE | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_002426 | | Name: | Corramycin | | Formula: | C51 H81 N11 O21 | | Definition date: | 2023-08-16 | | Last modified: | 2023-08-16 |
|
 | | PRD_002432 | | Name: | Pam3-SKKKK | | Formula: | C81 H160 N10 O13 S | | Definition date: | 2023-07-12 | | Last modified: | 2023-07-12 |
|
 | | PRD_002528 | | Name: | 142D6 | | Formula: | C26 H37 F N4 O6 S | | Description: | Lys-covalent pan-IAP inhibitor | | Definition date: | 2023-07-12 | | Last modified: | 2023-07-12 |
|
 | | PRD_002527 | | Name: | Intermediate for maxamycins synthesis | | Formula: | C84 H114 Cl2 N8 O17 S Si2 | | Definition date: | 2023-07-05 | | Last modified: | 2023-07-05 |
|
 | | PRD_002431 | | Name: | Cyclic tetraadenosine monophosphate (cA4) | | Formula: | C40 H48 N20 O24 P4 | | Description: | Cyclic oligoadenylates such as c-tetraAMP were found to be novel bacterial second messengers. Antiviral in context of signalling for Type III CRISPR-Cas systems. | | Definition date: | 2023-07-12 | | Last modified: | 2023-07-03 |
|
 | | PRD_001065 | | Name: | teicoplanin | | Formula: | C88 H97 Cl2 N9 O34 | | Definition date: | 2013-05-29 | | Last modified: | 2023-06-11 |
|
 | | PRD_002268 | | Name: | Lipid II | | Formula: | C54 H91 N8 O26 P2 | | Definition date: | 2020-08-19 | | Last modified: | 2023-06-11 |
|
 | | PRD_002330 | | Name: | Darobactin | | Formula: | C47 H56 N11 O12 | | Definition date: | 2021-04-21 | | Last modified: | 2023-06-11 |
|
 | | PRD_002342 | | Formula: | C51 H66 N14 O11 | | Definition date: | 2022-04-06 | | Last modified: | 2023-06-11 |
|
 | | PRD_002346 | | Name: | Inhibitor ARC-3126 | | Formula: | C58 H108 Br N31 O9 S | | Definition date: | 2021-08-04 | | Last modified: | 2023-06-11 |
|
 | | PRD_002353 | | Name: | Blood group B type 1 antigen, beta anomer | | Formula: | C26 H45 N O20 | | Definition date: | 2022-03-02 | | Last modified: | 2023-06-11 |
|
 | | PRD_002470 | | Name: | Agrocinopine A (alpha-L-arabinopyranose form) | | Formula: | C17 H31 O18 P | | Description: | phosphodiester of sucrose and L-arabinose | | Definition date: | 2023-05-24 | | Last modified: | 2023-05-24 |
|
 | | PRD_002441 | | Name: | Myxovalargin B | | Formula: | C80 H136 N21 O17 | | Definition date: | 2023-01-25 | | Last modified: | 2023-05-11 |
|
 | | PRD_002442 | | Name: | Myxovalargin A | | Formula: | C81 H138 N21 O17 | | Definition date: | 2023-01-18 | | Last modified: | 2023-05-11 |
|
 | | PRD_002366 | | Name: | Phalloidin | | Formula: | C35 H48 N8 O11 S | | Definition date: | 2021-12-22 | | Last modified: | 2023-05-09 |
|
 | | PRD_002419 | | Name: | Cyclomarin A | | Formula: | C56 H82 N8 O11 | | Definition date: | 2023-03-29 | | Last modified: | 2023-03-29 |
|
 | | PRD_002516 | | Name: | cyclic peptide inhibitor 1 | | Formula: | C111 H132 N23 O30 S | | Definition date: | 2023-03-22 | | Last modified: | 2023-03-22 |
|
 | | PRD_002425 | | Name: | Drosocin | | Formula: | C98 H166 N34 O24 | | Definition date: | 2023-03-08 | | Last modified: | 2023-03-08 |
|
